FATAL SIGAL enters CHEMOMAB THERAPEUTICS LTD. with 5.21K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/5/2023ACC: 0001178913-23-002162
Officer· Chief Financial Officer
Since Mar 2021
5.21K
Baseline shares
100% direct
5.21K
Direct ownership
1 position
65K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
American Depositary Shares
DirectShares owned5.21K
Total
5.21K direct5.21K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares | 5.21K | Direct |
| Total | 5.21K | 5.21K direct |
Derivative Holdings2
Options to purchase American Depositary Shares
DirectUnderlying security
American Depositary Shares
Underlying shares
35.60K
Shares owned
N/A
Exercise price
9.83
Expiration
—
Exercise window
—
Options to purchase American Depositary Shares
DirectUnderlying security
American Depositary Shares
Underlying shares
29.40K
Shares owned
N/A
Exercise price
2.11
Expiration
—
Exercise window
—
Total
Underlying
65K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to purchase American Depositary Shares Direct | American Depositary Shares | 9.83 | — | — | 35.60K | N/A |
| Options to purchase American Depositary Shares Direct | American Depositary Shares | 2.11 | — | — | 29.40K | N/A |
| Total | 65K | 0.00 | ||||